Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.1M Sell
148,040
-2,376
-2% -$527K 0.01% 1939
2025
Q4
$24.4M Sell
150,416
-15,068
-9% -$2.62M ﹤0.01% 2397
2025
Q3
$25M Sell
165,484
-200,852
-55% -$26.8M ﹤0.01% 2322
2025
Q2
$47M Sell
366,336
-741,236
-67% -$72.1M 0.01% 1579
2025
Q1
$80M Buy
1,107,572
+425,672
+62% +$45.3M 0.01% 1081
2024
Q4
$77.5M Sell
681,900
-250,400
-27% -$29.7M 0.01% 1092
2024
Q3
$92.8M Buy
932,300
+166,198
+22% +$13.8M 0.02% 762
2024
Q2
$66.3M Sell
766,102
-365,298
-32% -$33.3M 0.02% 856
2024
Q1
$92.4M Buy
+1,131,400
New +$71.1M 0.02% 686
2023
Q4
Sell
-66,800
Closed -$2.48M 9931
2023
Q3
$2.48M Buy
+66,800
New +$2.2M ﹤0.01% 3230

Other funds holding VRT

UBS Group's VRT Position: Q1 2026 in Review

UBS Group increased its Vertiv (VRT) stake by 69% in Q1 2026, buying an estimated $496M and bringing the position to 5,448,573 shares worth $1.37B. The position accounts for 0.2% of the portfolio, ranked #83.

UBS Group first reported a position in VRT in Q2 2019 and has held it in 28 quarters since. 1,824 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • UBS Group held 5,448,573 shares of Vertiv worth $1.37B as of Q1 2026.
  • UBS Group bought 2,232,208 Vertiv shares in Q1 2026, an estimated $496M.
  • Vertiv made up 0.2% of UBS Group's portfolio in Q1 2026, its #83 holding.
  • UBS Group first reported a position in Vertiv in Q2 2019 and has held it in 28 quarters since.
  • 1,824 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.